Latest Blogs

Women in Oncology
May 25, 2018
Connect, Collaborate, and Learn at #ASCO18 Women's Networking Center
Dr. Jane Lowe Meisel shares a first look at the program for the Women's Networking Center at the 2018 ASCO Annual Meeting. 
Guest Commentary
May 25, 2018
Expect Innovation, Excellence at ASCO Research Community Forum 2018 Annual Meeting
Dr. Edward S. Kim encourages you to register today and join the Research Community Forum in September for 2 days of learning and collaboration.
Nagi S. El Saghir, MD, FACP, FASCO
May 24, 2018
Pan-Arab Cancer Congress 2018 in Tunisia: Science and Patient Care Never Stop
In the midst of troubles in North Africa and Middle East, we keep up with oncology education and research and keep up hope for the betterment of patient care and advancement of science in Arab countries. 
Clifford A. Hudis, MD, FACP, FASCO
May 24, 2018
Biosimilars: A Conversation With Dr. Gary H. Lyman
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
Subscribe to this column

Gilberto Lopes, MD, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor in chief of ASCO's Journal of Global Oncology, associate editor for the ASCO University Editorial Board, 2016-2017 chair of the International Clinical Trials Workshop Working Group, and global health track leader for the Cancer Education Committee, among other volunteer roles. Follow him on Twitter @GlopesMd.

Nov 20, 2017
JGO: Our Voice for Global Oncology
A journal that aims to be the voice of global oncology has to publish work relating not only to differences in cancer biology due to risk factors, pathogenesis, and pharmacology, but also disparities arising from social, cultural, economic, and political resource-constraining issues.
Jul 26, 2017
Cervical Cancer in Latin America
My coauthors and I identify deficiencies in prevention and screening efforts that could be acted upon to further reduce cervical cancer incidence and mortality in Latin America.
Mar 20, 2017
The State of Lung Cancer in Latin America
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Oct 31, 2016
Rio 2016 Olympics, the Brazilian Economy, and Oncology: Where Are We Going Next?
Hope springs eternal in the Brazilian economy and health care system, with cautious optimism for gains in oncology care.
Oct 04, 2016
On Sakura Sogoro, Bottom-Up Social Movements, Biosimilars, and Access to Cancer Treatments
Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole problem.
Aug 01, 2016
Revisiting Cancer Control in Latin America and the Caribbean
The region has seen structural reforms in health care systems, better training of cancer professionals, new initiatives for populations at high risk, expansion of cancer registries and cancer plans, and implementation of policies to improve prevention, early diagnosis, and treatment.

Pages